Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Sylebra Capital Management and Impinj Inc

Page 2 of 3 – SEC Filing

CUSIP No.: 453204109
1
NAME OF REPORTING PERSON:
Sylebra Capital Management Limited
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
[   ] (a)
[   ] (b)

3SEC USE ONLY

4SOURCE OF FUNDS:

OO

5CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

[   ]

6CITIZENSHIP OR PLACE OF ORGANIZATION

Sylebra Capital Management Limited is organized in the Cayman Islands

NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH7SOLE VOTING POWER

0

8SHARED VOTING POWER

4,231,582 shares

9SOLE DISPOSITIVE POWER

0

10SHARED DISPOSITIVE POWER

4,231,582 shares

11AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,231,582 shares

12CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

[   ]

13PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

19.7%

14TYPE OF REPORTING PERSON

HC
Follow Impinj Inc
Trade (PI) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.